PV Bulletin

Beckman Coulter Iris iQ200 and DxU 840m/850m Analyzers Safety Notification

Urgent safety measures implemented for Beckman Coulter Iris iQ200 and DxU 840m/850m analyzers due to leakage issues.

Primary source: Téléchargez le courrier de la société Beckman Coulter (31/08/2026)

Translated From French

PV Bulletin does not take any responsibility for translation errors or omissions, though it has used the best available translation engine.

PV Impact Brief

Urgency: HighConfidence: high

What changed

Beckman Coulter has mandated an urgent safety corrective measure regarding analyzer performance, particularly related to liquid leakage detection and reporting.

Why it matters

This safety issue could lead to hazardous conditions in laboratory environments, heightening the risk of physical injuries to staff, which underscores the necessity for immediate corrective actions and thorough monitoring.

Action needed

All users of the affected analyzers are required to reply to the notification letter within 10 days and implement increased monitoring of device performance to prevent liquid leaks.

Relevant for
Regulatory Intelligence Lead
Processes impacted
Signal Management
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Evidence and confidence

Confidence: highSource updated: Aug 31, 2026

Full briefing

Practical implication

All users of the affected analyzers are required to reply to the notification letter within 10 days and implement increased monitoring of device performance to prevent liquid leaks.

Beckman Coulter has issued an urgent safety notice concerning potential liquid leaks from the Iris iQ200 and DxU 840m/850m analyzers due to structural failure of the backflow valve in the rinsing line. This may pose a risk of slips and falls for laboratory personnel, though it does not affect patient results.

What changed: Beckman Coulter has mandated an urgent safety corrective measure regarding analyzer performance, particularly related to liquid leakage detection and reporting.

Why it matters: This safety issue could lead to hazardous conditions in laboratory environments, heightening the risk of physical injuries to staff, which underscores the necessity for immediate corrective actions and thorough monitoring.

Practical implication: All users of the affected analyzers are required to reply to the notification letter within 10 days and implement increased monitoring of device performance to prevent liquid leaks.

View original source

  • Source: ANSM (France) - Safety information feed
  • Published at source: 2026-08-31T00:00:00.000Z
  • Discovered by monitor: 2026-08-31T21:32:57.872Z

Published from the regulator source ingestion pipeline after PV impact triage.

Related updates for your role

publicFDA · USA · Updated Aug 31, 2026

International Collaboration to Advance New Testing Methods That Reduce Reliance on Horseshoe Crab Blood

Urgency: High

Regulatory compliance processes may need updates to incorporate the new recombinant endotoxins testing method and guidelines established under the ICMRA framework.

Inspection ReadinessCountry ComplianceRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, PV Quality Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Aug 31, 2026Translated From French

Withdrawal of FastPen 40mg Product by AZRL LTD

Urgency: High

AZRL LTD must proceed with the recall of FastPen 40mg from all locations and suspend marketing activities until compliance is verified.

Signal ManagementRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Aug 31, 2026Translated From French

ANSM (France) - Safety information feed: Ventilateur d'anesthésie – Systèmes d’anesthésie Aisys et AisysCS2 – GE Healthcare / Datex-Ohmeda sur le site de l'Agence nationale de sécurité du médicamentet des produits de santé Information de sé

Urgency: High

Healthcare facilities must complete preoperative checks, manage emergency O2 flow during usage, and return the response form to GE Healthcare within a maximum of 30 days.

Signal ManagementRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Aug 31, 2026Translated From French

ANSM (France) - Safety information feed: Mycologie – Réactif Yeastone Broth, 11ML – Thermo Fisher Scientific sur le site de l'Agence nationale de sécurité du médicamentet des produits de santé Information de sécurité - Mycologie – Réactif Yeasto

Urgency: High

Laboratories must immediately quarantine and return the affected product, and communicate with patients to manage their follow-up testing appropriately.

Signal ManagementCountry ComplianceRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward